Decision Tool

Cardiac ASC Calculator

Compare real physician economics: AlignedCardio partnership vs. independent ASC build. Adjust volume, vendor terms, execution risk, and exit multiple. Built from the SHRC proforma — no login required.

Volume Assumptions

Vendor Deal Assumptions

Vendor subsidy$2.2M

Supply premium over market20%

Premium applies only during commitment period, then drops to $0

Exit EBITDA multiple8x

Applied to Year 5 EBITDA for equity value at exit

Execution Risk — Independent Path Only

AlignedCardio absorbs 100% of cost overruns and opening delays. The physician group carries these entirely on the independent path.

Execution risk75%

Dev cost overrun

75%

Opening delay

14 mos

View Period

Independent — vendor financed

Cases

Revenue

Supply premium

Commitment payoff

Cost overrun (amort./yr)

Delay EBITDA loss (Yr 1)

Total capital at risk

Execution risk100% physician

AlignedCardio platformNone

AlignedCardio partnership — 30% to group

Cases

Revenue

Supply premium$0

Commitment payoffN/A

Cost overrun riskAC absorbs

Delay riskAC absorbs

Capital at risk$0

Execution riskShared with AC

AlignedCardio platformYes — referrals + ops

Annual Cash Comparison — $000s

Independent (after exec risk) AlignedCardio 30%

Independent path shows full facility EBITDA; AlignedCardio path shows physician net share (30%). Not a direct comparison.

Proforma anchors (SHRC model)
Total project cost: $4.0M · AC equity contribution: $388K · Equipment loan: $1.149M · Yr 1 EBITDA: $313K (9.6% margin) · Yr 5 EBITDA: $1.275M (21.4% margin) · Revenue CAGR: 16.2% · 5-yr physician cumulative net (base): $1.27M · 5-yr AC cumulative income: $4.93M

Cardiac ASC Calculator

Ready to run the numberson your practice?

Ready to run the numbers
on your practice?